EPTIS
BAM Logo

Antibodies against SARS-CoV-2

[Antikörper gegen SARS-CoV-2]

EPTIS factsheet 907768 | Last revision 2021-11-25 | URL: https://www.eptis.bam.de/pts907768 https://www.eptis.bam.de/pts907768

PT provider
PT provider Institut für Qualitätssicherung Lübeck (IfQ-Lübeck) Institut für Qualitätssicherung Lübeck (IfQ-Lübeck)
Based in Germany
Language(s) German, English
Remarks
Keywords
Product groups Human test material
Testing fields Medical analysis
Technical details
Test item Tested property Testing method
Human serum or plasma Anti-SARS-CoV-2 (NCP) IgG Immunoblot
ELISA
Anti-SARS-CoV-2 (S1) IgG Indirect ImmunoFlourescence (IIF)
Other methods
Neutralizing antibodies -
-
Aims of the PT scheme
Target group of participants
Linked to specific legislation / standards
Additional, subsidiary aims
Number of participants
Accredited or otherwise reviewed by a 3rd party

Accredited by DAkkS on the basis of DIN EN ISO/IEC 17043

Operation is commissioned / requested by
Fees and frequency
Participation fee under www.ifq-portal.de
Regularly operated Yes (twice a year)
Year of first operation 2022
Contact details of the PT provider
Provider Contact person
Institut für Qualitätssicherung Lübeck (IfQ-Lübeck)
Seekamp 31
23560 Lübeck
Germany

Phone: +49-451-29288233
Fax: +49-451-29288591
Web: http://www.ifq-portal.de http://www.ifq-portal.de
Dr. Monika Probst
Phone: +49-451-585525751
Fax: +49-451-29288591
Email: m.probst@euroimmun.de m.probst@euroimmun.de
If you find any mistakes please contact the responsible EPTIS coordinator in Germany, Mr Johannes van de Kreeke. Mr Johannes van de Kreeke.
Any questions or problems? Please contact us at eptis@bam.de.
Application version: 1.21